Graphical Abstract
![](https://wqketang.oss-cn-beijing.aliyuncs.com/zip-unzip/zip-ed0c5bfc-92b0-43b4-90e0-74103bca0a3b/ntm-2-1-9130015/files/ntm-2-1-9130015-FE1.jpg?Expires=1725757694&OSSAccessKeyId=STS.NT5eViCkqzTYdbfdqxMkjpyyq&Signature=L3nfrhu3dC4uOlKTLz04ccG4e1Q%3D&security-token=CAISywJ1q6Ft5B2yfSjIr5eALuzdrrRQzZayZkTXgHEtQeRGn7zSkzz2IHtKenhsBOsbtfk1mG5W5%2FgZlqJ9SptIAEfJa9d99MzUP%2FpFltCT1fau5Jko1beHewHKeTOZsebWZ%2BLmNqC%2FHt6md1HDkAJq3LL%2Bbk%2FMdle5MJqP%2B%2FUFB5ZtKWveVzddA8pMLQZPsdITMWCrVcygKRn3mGHdfiEK00he8TouufTinpHMskGA1Aell7Mvyt6vcsT%2BXa5FJ4xiVtq55utye5fa3TRYgxowr%2Fwo0v0YpGya5YzHXwcPskvdKZbo78UqLQlla6w%2BGqFJqvPxr%2Fp8t%2Fx5fWJKAezhVgs8cVM8JOjIqKOscIsiJsO71SmqFV55c8Fdm%2BgUooJVgIMhTnduUfAPJAGOxzJitP%2BUVGGphr60TEnBL4rB5MUctfzRp75SXVPUTzDnGoABjuNLcf76FQN6p3t%2BSlCg%2FxR5C72RIk78k%2BUi44L9ZBmFT6F8GV7aXA52D1Ps56knKF6PAnhRivwyTxgsolycBfvccb3t5jGJ24SgY0aYosAECutxAo7sJhSwlwZvGwGDZJsop1vGiZ8eN1MbtZeRRuMeaZ2I%2BQo%2BnVP6Cf%2F0pDsgAA%3D%3D)
Discover the SciOpen Platform and Achieve Your Research Goals with Ease.
Clinical features and the dynamic changes of the immune response in coronavirus disease-2019 (COVID-19) patients play essential roles in the disease courses. We hypothesized that clinical features and longitudinal dynamic immune response of COVID-19 patients might be associated with viral shedding duration.
In this retrospective study, we documented 413 adult patients with laboratory-confirmed COVID-19 from Wuhan Huoshenshan Hospital. Demographic, clinical, and laboratory data were extracted from electronic medical records. Risk factors associated with viral shedding duration were examined using odds ratios (ORs) and 95% confidence intervals (CIs) in the multivariable logistic regression models.
The median duration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral shedding was 48 days (interquartile range, 40–58 days) among all patients. Fever symptom (OR, 2.23; 95% CI, 1.46–3.44), delayed admission after symptom onset (OR, 15.33; 95% CI, 9.14–26.65), CD8+ T cells (OR, 1.93; 95% CI, 1.10–3.44) were associated with prolonged viral shedding. In contrast, shorter viral shedding was associated with CD4+ T cells (OR, 0.38; 95% CI, 0.16–0.88), the ratios of CD4+ T cells to CD8+ T cells (OR, 0.79; 95% CI, 0.63–0.98). Longitudinal dynamic analyses demonstrate that sustained monocyte level was associated with shorter viral shedding (OR, 0.41; 95% CI, 0.22–0.76). More importantly, the associations of CD4+ T cells, CD8+ T cells, the ratio of CD4+ T cells to CD8+ T cells, and sustained monocyte level were confined to male patients.
Higher CD4+ T cells, sustained monocyte level, and lower CD8+ T cells might shorten the disease course. The male-specific associations supported the contribution of sex-dependent immune responses to the disease courses.
Zhu, N.; Zhang, D. Y.; Wang, W. L.; Li, X. W.; Yang, B.; Song, J. D.; Zhao, X.; Huang, B. Y.; Shi, W. F.; Lu, R. J. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020, 382, 727–733.
Wu, Z. Y.; McGoogan, J. M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72,314 cases from the Chinese center for disease control and prevention. JAMA 2020, 323, 1239–1242.
Zhou, P.; Yang, X. L.; Wang, X. G.; Hu, B.; Zhang, L.; Zhang, W.; Si, H. R.; Zhu, Y.; Li, B.; Huang, C. L. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020, 579, 270–273.
Young, B. E.; Ong, S. W. X.; Kalimuddin, S.; Low, J. G.; Tan, S. Y.; Loh, J.; Ng, O. T.; Marimuthu, K.; Ang, L. W.; Mak, T. M. et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA 2020, 323, 1488–1494.
Li, N.; Wang, X.; Lv, T. F. Prolonged SARS-CoV-2 RNA shedding: Not a rare phenomenon. J. Med. Virol. 2020, 92, 2286–2287.
Le, T. Q. M.; Takemura, T.; Moi, M. L.; Nabeshima, T.; Nguyen, L. K. H.; Hoang, V. M. P.; Ung, T. H. T.; Le, T. T.; Nguyen, V. S.; Pham, H. Q. A. et al. Severe acute respiratory syndrome coronavirus 2 shedding by travelers, Vietnam, 2020. Emerg. Infect. Dis. 2020, 26, 1624–1626.
Cevik, M.; Tate, M.; Lloyd, O.; Maraolo, A. E.; Schafers, J.; Ho, A. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: A systematic review and meta-analysis. Lancet Microbe. 2021, 2, e13–e22.
Zou, L. R.; Ruan, F.; Huang, M. X.; Liang, L. J.; Huang, H. T.; Hong, Z. S.; Yu, J. X.; Kang, M.; Song, Y. C.; Xia, J. Y. et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N. Engl. J. Med. 2020, 382, 1177–1179.
Wölfel, R.; Corman, V. M.; Guggemos, W.; Seilmaier, M.; Zange, S.; Müller, M. A.; Niemeyer, D.; Jones, T. C.; Vollmar, P.; Rothe, C. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 2020, 581, 465–469.
van Kampen, J. J. A.; van de Vijver, D. A. M. C.; Fraaij, P. L. A.; Haagmans, B. L.; Lamers, M. M.; Okba, N.; van den Akker, J. P. C.; Endeman, H.; Gommers, D. A. M. P. J.; Cornelissen, J. J. et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). Nat. Commun. 2021, 12, 267.
Zheng, S. F.; Fan, J.; Yu, F.; Feng, B. H.; Lou, B.; Zou, Q. D.; Xie, G. L.; Lin, S.; Wang, R. N.; Yang, X. Z. et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January–March 2020: Retrospective cohort study. BMJ 2020, 369, m1443.
Xu, K. J.; Chen, Y. F.; Yuan, J.; Yi, P.; Ding, C.; Wu, W. R.; Li, Y. T.; Ni, Q.; Zou, R. R.; Li, X. H. et al. Factors associated with prolonged viral RNA shedding in patients with coronavirus disease 2019 (COVID-19). Clin. Infect. Dis. 2020, 71, 799–806.
Xiao, A. T.; Tong, Y. X.; Zhang, S. Profile of RT-PCR for SARS-CoV-2: A preliminary study from 56 COVID-19 patients. Clin. Infect. Dis. 2020, 71, 2249–2251.
Qi, L.; Yang, Y.; Jiang, D. X.; Tu, C.; Wan, L.; Chen, X. Y.; Li, Z. H. Factors associated with the duration of viral shedding in adults with COVID-19 outside of Wuhan, China: A retrospective cohort study. Int. J. Infect. Dis. 2020, 96, 531–537.
Fu, Y.; Han, P.; Zhu, R.; Bai, T.; Yi, J. H.; Zhao, X.; Tao, M. H.; Quan, R. Z.; Chen, C. Y.; Zhang, Y. et al. Risk factors for viral RNA shedding in COVID-19 patients. Eur. Respir. J. 2020, 56, 2001190.
Fontana, L. M.; Villamagna, A. H.; Sikka, M. K.; McGregor, J. C. Understanding viral shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Review of current literature. Infect. Control Hosp. Epidemiol. 2021, 42, 659–668.
Zhou, M.; Yu, F. F.; Tan, L.; Zhu, Y. D.; Ma, N.; Song, L. J.; Li, Q.; Liu, Y.; Zou, Z.; Xu, T. Y.; et al. Clinical characteristics associated with long-term viral shedding in patients with coronavirus disease 2019. Am. J. Transl. Res. 2020, 12, 6954–6964.
Zhou, B.; She, J. Q.; Wang, Y. D.; Ma, X. C. Duration of viral shedding of discharged patients with severe COVID-19. Clin. Infect. Dis. 2020, 71, 2240–2242.
Takahashi, T.; Ellingson, M. K.; Wong, P.; Israelow, B.; Lucas, C.; Klein, J.; Silva, J.; Mao, T. Y.; Oh, J. E.; Tokuyama, M. et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature 2020, 588, 315–320.
Li, K. N.; Huang, B.; Wu, M.; Zhong, A. F.; Li, L.; Cai, Y.; Wang, Z. H.; Wu, L. X.; Zhu, M. Y.; Li, J. et al. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19. Nat. Commun. 2020, 11, 6044.
Chen, Y. Z.; Zuiani, A.; Fischinger, S.; Mullur, J.; Atyeo, C.; Travers, M.; Lelis, F. J. N.; Pullen, K. M.; Martin, H.; Tong, P. et al. Quick COVID-19 healers sustain anti-SARS-CoV-2 antibody production. Cell 2020, 183, 1496–1507.e16.
Grifoni, A.; Weiskopf, D.; Ramirez, S. I.; Mateus, J.; Dan, J. M.; Moderbacher, C. R.; Rawlings, S. A.; Sutherland, A.; Premkumar, L.; Jadi, R. S. et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 2020, 181, 1489–501.e15.
Chen, Z. Y.; John Wherry, E. T cell responses in patients with COVID-19. Nat. Rev. Immunol. 2020, 20, 529–536.
de Candia, P.; Prattichizzo, F.; Garavelli, S.; Matarese, G. T cells: Warriors of SARS-CoV-2 infection. Trends Immunol. 2021, 42, 18–30.
Chen, G.; Wu, D.; Guo, W.; Cao, Y.; Huang, D.; Wang, H. W.; Wang, T.; Zhang, X. Y.; Chen, H. L.; Yu, H. J. et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Invest. 2020, 130, 2620–2629.
Chen, J.; Lau, Y. F.; Lamirande, E. W.; Paddock, C. D.; Bartlett, J. H.; Zaki, S. R.; Subbarao, K. Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection. J. Virol. 2010, 84, 1289–1301.
Peng, Y. C.; Mentzer, A. J.; Liu, G. H.; Yao, X.; Yin, Z. X.; Dong, D. N.; Dejnirattisai, W.; Rostron, T.; Supasa, P.; Liu, C. et al. Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat. Immunol. 2020, 21, 1336–1345.
Vibholm, L. K.; Nielsen, S. S. F.; Pahus, M. H.; Frattari, G. S.; Olesen, R.; Andersen, R.; Monrad, I.; Andersen, A. H. F.; Thomsen, M. M.; Konrad, C. V. et al. SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses. eBioMedicine 2021, 64, 103230.
Wen, W.; Su, W. R.; Tang, H.; Le, W. Q.; Zhang, X. P.; Zheng, Y. F.; Liu, X. X.; Xie, L. H.; Li, J. M.; Ye, J. G. et al. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov. 2020, 6, 31.
Liao, M. F.; Liu, Y.; Yuan, J.; Wen, Y. L.; Xu, G.; Zhao, J. J.; Cheng, L.; Li, J. X.; Wang, X.; Wang, F. X. et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat. Med. 2020, 26, 842–844.
Merad, M.; Martin, J. C. Pathological inflammation in patients with COVID-19: A key role for monocytes and macrophages. Nat. Rev. Immunol. 2020, 20, 355–362.
Martinez, F. O.; Combes, T. W.; Orsenigo, F.; Gordon, S. Monocyte activation in systemic Covid-19 infection: Assay and rationale. eBioMedicine 2020, 59, 102964.
Zhang, D.; Guo, R.; Lei, L.; Liu, H. J.; Wang, Y. W.; Wang, Y. L.; Qian, H. B.; Dai, T. X.; Zhang, T. X.; Lai, Y. J. et al. Frontline science: COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes. J. Leukoc. Biol. 2021, 109, 13–22.
Vetter, P.; Eberhardt, C. S.; Meyer, B.; Martinez Murillo, P. A.; Torriani, G.; Pigny, F.; Lemeille, S.; Cordey, S.; Laubscher, F.; Vu, D. L. et al. Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: A case series. mSphere 2020, 5, e00827-20.
Meng, Y. F.; Wu, P.; Lu, W. R.; Liu, K.; Ma, K.; Huang, L.; Cai, J. J.; Zhang, H.; Qin, Y.; Sun, H. Y. et al. Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients. PLoS Pathog. 2020, 16, e1008520.
Jin, J. M.; Bai, P.; He, W.; Wu, F.; Liu, X. F.; Han, D. M.; Liu, S.; Yang, J. K. Gender differences in patients with COVID-19: Focus on severity and mortality. Front. Public Health 2020, 8, 152.
Chen, N. S.; Zhou, M.; Dong, X.; Qu, J. M.; Gong, F. Y.; Han, Y.; Qiu, Y.; Wang, J. L.; Liu, Y.; Wei, Y. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020, 395, 507–513.
Ursin, R. L.; Shapiro, J. R.; Klein, S. L. Sex-biased immune responses following SARS-CoV-2 infection. Trends Microbiol. 2020, 28, 952–954.
Scully, E. P.; Haverfield, J.; Ursin, R. L.; Tannenbaum, C.; Klein, S. L. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat. Rev. Immunol. 2020, 20, 442–447.
Ellegren, H.; Parsch, J. The evolution of sex-biased genes and sex-biased gene expression. Nat. Rev. Genet. 2007, 8, 689–698.
Ober, C.; Loisel, D. A.; Gilad, Y. Sex-specific genetic architecture of human disease. Nat. Rev. Genet. 2008, 9, 911–922.
Sieurin, J.; Brandén, G.; Magnusson, C.; Hergens, M. P.; Kosidou, K. A population-based cohort study of sex and risk of severe outcomes in covid-19. Eur. J. Epidemiol. 2022, 37, 1159–1169.
Zhao, G. L.; Xu, Y. Z.; Li, J.; Cui, X. L.; Tan, X. W.; Zhang, H. Y.; Dang, L. Y. Sex differences in immune responses to SARS-CoV-2 in patients with COVID-19. Biosci. Rep. 2021, 41, BSR20202074.
The articles published in this open access journal are distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.